Share Prices & Company Research

Market News

11 Mar 2021 | 14:01

EU approves J&J Covid-19 vaccine for use in people 18 and over

(Sharecast News) - Europe's main drugs regulator gave the green-light to Johnson&Johnson's Covid-19 vaccine, a move that it was hoped would help the bloc accelerate its inoculation programme. The European Medicines Agency recommended the vaccine for use in people aged 18 and over.

J&J's vaccine has two key advantages over those of rivals, including the fact that it only requires a single dose and that it can be stored for long periods in normal refrigerators.

Brussels had bought 200.0m doses with an option to double that number.

However, there were now doubts about whether J&J would begin shipments in April, as previously announced by the European Commission.

Indeed, the drug giant had reportedly yet to provide a delivery schedule for its vaccine.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.